key: cord-0802979-y96etagf
authors: Qiu, Yang; Wu, Di; Ning, Wanshan; Xu, Jiqian; Shu, Ting; Huang, Muhan; Chen, Rong; Zhang, Jiancheng; Han, Yang; Yang, Qingyu; Li, Ruiting; Yang, Xiaobo; Wang, Yaxin; Zou, Xiaojing; Pan, Shangwen; Huang, Chaolin; Xue, Yu; Shang, You; Zhou, Xi
title: Post-mortem tissue proteomics reveals the pathogenesis of multi-organ injuries of COVID-19
date: 2021-08-10
journal: Natl Sci Rev
DOI: 10.1093/nsr/nwab143
sha: c027ee7d13beb54cc2569dc6e4bcec316c5eacdc
doc_id: 802979
cord_uid: y96etagf

nan

COVID-19 is caused by SARS-CoV-2, which is the third coronavirus to cause severe 120 respiratory disease in humans besides SARS-CoV and Middle East respiratory syndrome 121 coronavirus (MERS-CoV). Since its emergence from late 2019 [13] , the outbreak of SARS-CoV-122 2 has resulted in tremendous impacts on global health, social and economics, making COVID-19 123 a global pandemic and the worst public health crisis once a century. 124 About 20% COVID-19 patients have been reported to develop severe or critical conditions 125 [14] , and the mortality rate of critically ill cases can reach over 60% [15] . The main targets of 126 SARS-CoV-2 are human low respiratory tract and lung, while many other organs, including liver, 127 heart, intestine, kidney, central nervous system and muscle have been also found to be injured [16-128 18] . Among the broad symptoms of COVID-19, fever, pneumonia, respiratory failure, acute 129 respiratory distress syndrome (ARDS), 130 and sepsis are frequently observed complications, which are usually associated with 131 pathophysiological changes such as alveolar macrophage activation, lymphopenia, cytokine 132 release syndrome, thrombosis and intravascular coagulation in severe 13, . However, despite of extensive efforts made by global scientific community to study this 134 emerging coronavirus disease, the molecular mechanisms underlying its pathogenesis, particularly 135 the pathogenesis of COVID-19-associated multiorgan injuries, are still barely understood, which 136 represents a major obstacle to fully understand and find out effective ways to combat against this 137 deadly coronavirus disease. In this study, we provide the postmortem tissue proteomic datasets 138 that provides the most direct and reliable evidence of the pathophysiological changes of human 139 bodies in response to SARS-CoV-2 infections, and uncovers that SARS-CoV-2 infection affected 140 different set of host processes in different organs or tissues, which probably contribute to the 141 pathogenesis of COVID-19-associated multiorgan injuries. 142

One of the key findings obtained here is that proteins and pathways are differently altered in 143 distinct human tissues or organs in response to COVID-19. In a recent study, Nie et al. identified 144 that immune-and inflammation-related pathways were significantly up-regulated in multiple 145 organs, such as lung, spleen, heart, kidney, and thyroid [24] . However, our analysis found that 146 these processes, such as humoral immune response, complement activation, B-cell mediated 147 immunity, acute phase response and cytolysis, were upregulated only in lungs from all the tissues 148 examined, showing that excessive immune response and inflammation were extensively occurred 149 in lungs. Consistently, our histopathological examinations also showed that interstitial 150 mononuclear/macrophage cell infiltration and inflammation were presented in lung tissues. On the 151 other hand, cell morphology maintenance-related pathways were downregulated in lungs. These 152 results indicated that the microscopic structure of alveolar cells and lungs were severely damaged, 153 consistent with the postmortem pathological and histopathological observations in the current 154 study and by others that extensive fibromyxoid exudation, alveolar haemorrhage and thrombosis 155 were found in lungs [25, 26] . Therefore, we conclude that the excessive inflammation in lungs of 156 severe COVID-19 cases increases vascular permeability and activates coagulation cascades, 157 resulting in vascular thrombosis and probably a systemic hypoxia, and also causes a widespread 158 destruction of pulmonary architecture and functions. Our findings are in accordance with previous 159 clinical and autopsy observations that severe or critical ill COVID-19 patients are frequently 160 associated with massive intravascular thrombus, hypoxemia, and ARDS [13, 15, 17, 19-22, 25-161 27] , which are pathophysiologically associated with cytokine storm, alveolar macrophage 162 activation, intravascular coagulation and microthrombosis [11, 12, 23] . 163

On the other hand, unlike the host protein responses in lungs, our study revealed that the DEPs 164 in tissues of liver, kidney, intestine, brain, and heart are mainly present in pathways involved in 165 organ movement, respiration, and metabolism. For example, some shared altered pathways, 166 including muscle filament sliding and contraction, cellular respiration, NADH metabolic process, 167 hydrogen peroxide metabolic process, and glucose catabolic process, were found to be 168 significantly downregulated in kidney, liver, intestine, and brain, and these findings were highly 169 consistent with the Nie's study [24] . These results indicated that these tissues were affected by 170 hypoxia and their functions and morphology were dramatically impaired, which are consistent 171 with the previous clinical data that multiorgan failure are frequently observed complications in 172

severe 15, 20, 21] . Surprisingly, based on our proteomic data, very few 173 immune-or inflammation-related pathways were found to be significantly altered in other 174 organs/tissues, indicating that the leading cause of multiorgan injuries in non-lung organs/tissues 175 is hypoxia but not excessive inflammation. Thus, we propose that lung is the center of the virus- interacting DEPs in lung tissues, suggesting that these viral proteins directly affect the expressions 188 and/or functions of these interacting host proteins. Therefore, it would be intriguing to integrate 189 the omics data to generate a more comprehensive picture of the pathogenicity of SARS-CoV-2 190 and the pathogenesis of Taken together, our findings demonstrate the significant pathophysiological alternations of 192 host proteins/pathways associated with multiorgan injuries of which provides 193 invaluable knowledge about COVID-19-associated host responses and sheds light on the 194 pathogenesis of Supplementary Methods 196 Ethics and Human Subjects 197 All work performed in this study was approved by the Wuhan Jinyintan Hospital Ethics 198

Committee ( (Table S1 ). All the 206 patients had fever, cough and shortness of breath and progressed into ARDS due to severe 207 pulmonary lesions with significantly decreased lymphocytes. Finally, all these patients died of 208 respiratory failure. 209

We collected the samples of lung and muscle from patient 1, the samples of lung, heart, 210 liver, spleen, kidney, intestine, brain and muscle from patient 2, and the samples of lung, heart, 211 liver, spleen, kidney, brain and muscle from patient 3. Besides, lung paracancerous tissue samples 212 from 2 lung cancer patients (a 65-year-old male and a 57-year-old female) were collected for 213 comparison (Table S1 ). For all the three deceased COVID-19 patients, the interval time between 214 patient decease and autopsy was less than 1 h, and postmortem specimens were immediately frozen 215 in liquid nitrogen after dissection. All the samples were treated according to the biocontainment 216 procedures of the processing of SARS-CoV-2-positive sample. For the cancer patients, the 217 paracancerous tissue samples were resected from the patients and also immediately stored in liquid 218 nitrogen before further treatment. 219 220 Haematoxylin and eosin staining and immunofluorescence analysis 221

Tissues from the case were fixed with 4% paraformaldehyde for 24 h. Tissues were then 222 embedded in optimal cutting temperature (OCT) compound and cut into 3.5-μm sections using 223

Rotary Microtome (Thermo Scientific™ HM 355S). Mounted microscope slides were fixed with 224 paraformaldehyde and stained with haematoxylin and eosin for histopathological examination. 225

Slides were dewaxed with dimethylbenzene and gradient alcohol, antigen repaired with 226 ethylene diamine tetraacetic acid (pH=8.0), then blocked by incubating with 5% bovine serum 227 albumin (BIOSHARP, Hefei, China) at 37 °C for 30 min, followed by overnight incubation at 4 °C 228 with the rabbit anti-SARS-CoV-2 nucleocapsid protein (NP) antibody (1:200) Table S2 . After 15 min of incubation in the boiling water bath, the 245 samples were subjected to treatment with ultra-sonication. After centrifugation (12000 × g, 15 246 min), proteins in the supernatant were precipitated by adding 4 times of cold acetone. The protein 247 sample was dissolved in 8 M Urea/100 mM Tris-HCl (pH 8.0). After centrifugation, the 248 supernatant was used for reduction reaction (10 mM DTT, 37°C for 1 h), and followed by 249 alkylation reaction (40 mM iodoacetamide, room temperature/dark place for 30 min). Protein 250 concentration was measured by Bradford method. Urea was diluted below 2 M using 100 mM 251 Tris-HCl (pH 8.0). Trypsin was added at a ratio of 1:50 (enzyme: protein, w/w) for overnight 252 digestion at 37°C. The next day, trifluoroacetic acid (TFA) was used to bring the pH down to 6.0 253 to end the digestion. After centrifugation, the supernatant was subjected to peptide purification 254 using Sep-Pak C18 desalting column. The peptide eluate was dried in vacuum and stored at -20°C 255 for later use. 256

Tandem mass tag (TMT) labeling was performed according to manufacturer's instructions. 257

Briefly, peptides were reconstituted in TMT reagent buffer, and the samples were separately 258 labeled with different TMT labeling reagents. The labeled samples were then mixed and subjected 259

to Sep-Pak C18 desalting. The complex mixture was fractionated using high pH reversed-phase 260 liquid chromatography (RPLC) and combined into 20 fractions. Each fraction was dried in vacuum 261 and stored at -80°C until MS analysis. 262 263 LC-MS/MS analysis 264 LC-MS/MS data acquisition was carried out on a Q Exactive HF-X mass spectrometer 265 coupled with an Easy-nLC 1200 system (both Thermo Scientific). Peptides were first loaded onto 266 a C18 trap column (75 μm × 2 cm, 3 μm particle size, 100 Å pore size, Thermo) and then separated 267 in a C18 analytical column (75 μm × 250 mm, 3 μm particle size, 100 Å pore size, Thermo). Search results were filtered with 1% false discovery rate (FDR) at both protein and peptide levels. 289

Proteins denoted as decoy hits, contaminants, or only identified by sites were removed, and the 290 remaining proteins were used for further analysis. The proteomic data imputation and normalization was conducted using Perseus 1.6.14 [3]. 315

To test whether different tissue-specific proteomes could be distinguished, PCA was performed 316 using Scikit-learn 0.22.1 (https://scikit-learn.org/stable/), a powerful toolkit for data mining and 317 analysis. 318 319 Human normal proteomic data 320

From the HPM portal (http://humanproteomemap.org/) [8], pre-compiled proteomic datasets 321 of lung, kidney, liver, colon, frontal cortex and heart in adults were downloaded, containing 12, 335, 322 12,252, 16,800, 14,813, 16,868, and 12 ,007 quantified proteins, respectively. The HPM proteomic 323 datasets were also imputed and normalized by the same methods described above. 324 325 Identification of tissue-specific proteins 326

As previously described [4, 5] , an entropy-based method was adopted to identify potential 327 TSPs in human COVID-19 tissues. For each protein, its relative NPE (rNPE) value in a tissue j 328 was defined as below: 329

Where NPEj was the normalized expression value in the tissue j, and Σ NPE was the sum of all 331 NPE values in all tissue samples. N was the total number of COVID-19 tissues. Then, the Shannon 332 entropy H of this protein across different tissues could be calculated as below: 333

Where the value of H ranged from 0 to log2(N). A smaller H score represented a higher probability 335 of a protein to be a real TSP. Based on the distribution of H scores, proteins with entropy < 2.5 336 were reserved as potential TSPs. Then, the E-ratio was calculated, and the P value was computed with the hypergeometric 380 distribution as below: 381 E-ratio = 382

In this study, GO annotation files (on 03 January 2020) were downloaded from the Gene Ontology Figure S8 . Comparison of the DEPs identified in this study to other published proteomic studies 574 [24, 28, 31] , including in A, lung, B, kidney, C, liver, D, heart, and E, intestine. More details were 575 shown in Table S9 . 576 577 578 Figure S9 . A virus-host protein interaction network. In the network, the 308 up-(pink) and 579 down-regulated (cyan) DEPs in postmortem lung tissues were classified into 6 groups based on 580 their major functions. The PPIs between the 23 SARS-CoV-2 proteins (orange) were shown in 581 yellow links, whereas PPIs between host proteins were shown in grey links. analysis of SARS-CoV-2 interacting DEPs. Two-sided hypergeometric test, m > 5, P value < 0.01. 585

The clinical pathology of severe acute respiratory 421 syndrome (SARS): a report from

A pneumonia outbreak associated with a new 423 coronavirus of probable bat origin

The MaxQuant computational platform for mass 425 spectrometry-based shotgun proteomics

Promoter features related to tissue specificity as 427 measured by Shannon entropy

Epigenomic analysis of multilineage differentiation 429 of human embryonic stem cells

HemI: a toolkit for illustrating heatmaps

The GeneCards Suite: From Gene Data Mining to 433

Disease Genome Sequence Analyses

A draft map of the human proteome

MAP: model-based analysis of proteomic data to detect proteins 437 with significant abundance changes

A SARS-CoV-2 protein interaction map 439 reveals targets for drug repurposing

Cytokine release syndrome in severe COVID-19

Respiratory Virus Infections: Understanding COVID-19. 443 Immunity

Clinical features of patients infected with 2019 novel 445 coronavirus in Wuhan

Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) 448 -China

The Architecture of SARS-CoV-2 Transcriptome

Liver injury in COVID-19: management and challenges

Endothelial cell infection and endotheliitis in 454 COVID-19

Severe Acute Respiratory Syndrome 456

SARS-CoV-2) and the Central Nervous System

Clinical Characteristics of 138 Hospitalized Patients With 459 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Clinical Characteristics of Coronavirus Disease 2019 in 461 China

Epidemiological and clinical characteristics of 99 cases 463 of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Thrombocytopenia and its association with mortality in 466 patients with COVID-19

COVID-19 cytokine storm: the interplay between inflammation and 468 coagulation

Multi-organ proteomic landscape of COVID-19 autopsies

Angiogenesis in Covid-19

Pathological findings of COVID-19 associated with acute 474 respiratory distress syndrome

The procoagulant pattern of patients with 476 COVID-19 acute respiratory distress syndrome

Proteomics of SARS-CoV-2-infected host cells 478 reveals therapy targets

Proteomic and Metabolomic Characterization of COVID-19 480 Patient Sera

Plasma metabolomic and lipidomic alterations associated 482 with COVID-19

Pathological features of COVID-19-associated lung injury: a 484 preliminary proteomics report based on clinical samples

Targeted proteomics as a tool to 487 detect SARS-CoV-2 proteins in clinical specimens

Plasma Proteomics Identify Biomarkers and Pathogenesis 489 of COVID-19

Shotgun proteomics analysis of SARS-CoV-2-491 infected cells and how it can optimize whole viral particle antigen production for vaccines. Emerg 492 Microbes Infect

Dysregulation in Akt/mTOR/HIF-1 494 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells. Emerg Microbes 495 Infect

Proteomics Profiling of Host Cell Response via Protein 497 Expression and Phosphorylation upon Dengue Virus Infection

A new coronavirus associated with human respiratory disease 499 in China

Gene set enrichment analysis: a 501 knowledge-based approach for interpreting genome-wide expression profiles

The BioGRID interaction database: 2019 504 update

update: context-specific physical 506 protein-protein interactions in human, model organisms and domesticated species

A scored human protein-protein interaction 509 network to catalyze genomic interpretation

mentha: a resource for browsing integrated 511 protein-interaction networks

HINT: High-quality protein interactomes and their applications in 513 understanding human disease

iRefIndex: a consolidated protein interaction 515 database with provenance

Cytoscape: a software environment for integrated 519 models of biomolecular interaction networks

Evolution of enhanced innate immune 521 evasion by the SARS-CoV-2 B.1.1.7 UK variant. bioRxiv : the preprint server for biology